CTRI/2022/06/043082
Completed
Phase 2
Preclinical and clinical evaluation of the effect on oral administration of GANTHAGA NEI along with external therapy of NATHTHAICHOORI TAILAM in the management of CIRASTHAMPA VATHAM
Dr P RAJAVATHANA0 sites40 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: G801- Spastic diplegic cerebral palsyHealth Condition 2: G802- Spastic hemiplegic cerebral palsy
- Sponsor
- Dr P RAJAVATHANA
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Delay in motor and fine milestones
- •2\.Delay in intellectual and cognitive functional development
- •3\.Abnormal muscle tone and reflexes
Exclusion Criteria
- •1\.CP with severe seizure
- •2\.CP with other congenital associated disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreHealth Condition 1: G819- Hemiplegia, unspecifiedCTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of Siddha classical drug KARUNJEERAKA MATHIRAI (oral administration)along with application of NUNAA TAILAM(external) in the management of VITILIGO in childreCTRI/2022/01/039863Dr S Surendar
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYHealth Condition 1: E539- Vitamin B deficiency, unspecifiedCTRI/2022/02/039956Dr S Aiswarya40
Active, not recruiting
Phase 2
Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.CTRI/2022/01/039856Dr P Ponsridharani
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.Health Condition 1: E65- Localized adiposityHealth Condition 2: E660- Obesity due to excess caloriesHealth Condition 3: E663- OverweightCTRI/2022/02/040297Dr J Mangalavalli40